Herbs for seniors. Disseminating knowledge about plant ingredients acting against neurodegeneration
DOI:
https://doi.org/10.12775/HERB.2021.007Keywords
neurodegeneration diseases, seniors, herbal drugs, herbal preparation, herbal, old age dizeasesAbstract
Neurodegeneration diseases create an increasing problem in the societies where demographic profile changes due to the aging population. Herbal drugs, plant extracts, botanical supplements and spices that may act against neurodegeneration are appreciated. The questionnaire was projected and performed; 80 persons aged over 60 y completed the survey. Majority of seniors did not take herbal drugs but applied herbal preparations, food supplements and spices. Their knowledge on herbs
comes from books, newspapers and Internet and is not satisfactory. It is evident that herbal preparations should be promoted and recommended for seniors. The diet rich in vegetables, spices and herbs may decrease the risk of neurodegeneration diseases and slow down their progress.
References
Christensen K., Doblhammer G., Rau R., Vaupel J.W., Ageing populations: The challenges ahead, Lancet, 2009, 374, s. 1196–1208.
Wagner E., Choroby wieku podeszłego i rola leczenia usprawniającego w utrzymaniu dobrej kondycji fizycznej osób w podeszłym wieku, Kwartalnik Ortopedyczny, 2004, 4, s. 211–224.
Prince M., Guerchet M., Prina M., World Alzheimer Report 2013, Alzheimer’s Disease International, London, UK, 2013.
Nathan J., Panjwani S., Mohan V., Joshi V., Thakurdesai P.A., Efficacy and safety of standardized extract of Trigonella foenum-graecum L seeds as an adjuvant to L-Dopa in the management of patients with Parkinson’s disease, Phytotherapy Research, 2014,
(2), s. 172–178.
Zameer S., Najmi A.K., Vohora D., Akhtar M., A review on therapeutic potentials of Trigonella foenum graecum (fenugreek) and its chemical constituents in neurological disorders: Complementary roles to its hypolipidemic, hypoglycemic, and antioxidant potential, Nutrition Neuroscience, 2018, 21(8), s. 539–545.
Petersen M., Simmonds M.S., Rosmarinic acid, Phytochemistry, 2003, 62, s. 121–125.
Iuvone T., De Filippis D., Esposito G., D’Amico A., Izzo A.A., The spice sage and its active ingredient rosmarinic acid protect PC12 cells from amyloid-beta peptide-in- duced neurotoxicity, Journal of Pharmacology and Experimental Therapeutics, 2006, 317(3), s. 1143–1149.
Hamaguchi T., Ono K., Murase A., Yamada M., Phenolic compounds prevent Alzheimer’s pathology through different effects on the amyloid-beta aggregation pathway, American Journal of Pathology, 2009, 175(6), s. 2557–2565.
Kennedy D.O., Scholey A.B., Tildesley N.T.J., Perry E.K., Wesne K.A., Modulation of mood and cognitive performance following acute administration of Melissa officinalis (lemon balm) Pharmacology, Biochemistry and Behavior, 2002, 72, s. 953–964.
Nolkemper S., Reichling J., Stintzing F.C., Carle R., Schnitzler P., Antiviral effect of aqueous extracts from species of the Lamiaceae family against herpes simplex virus type 1 and type 2 in vitro, Planta Medica, 2006, s. 1378–1382.
Moreno S., Scheyer T., Romano C.S., Vojno, A.A., Antioxidant and antimicrobial activities of rosemary extracts linked to their polyphenol composition, Free Radical. Research, 2006, s. 223–231.
Liu H., Ye M., Guo H., An updated review of randomized clinical trials testing the improvement of cognitive function of Ginkgo biloba extract in healthy people and Alzheimer’s patients, Frontiers in Pharmacology, 2020, 10, s. 1688.
Hoerr R., Nacu A., Neuropsychiatric symptoms in dementia and the effects of Ginkgo biloba extract EGb 761® treatment: additional results from a 24-week randomized, placebo-controlled trial, Journal of Clinical. Trials, 2016, 8, s. 1–6.
Huang L., Zhao H., Huang B., Zheng C., Peng W., Qin L., Acanthopanax senticosus: review of botany, chemistry and pharmacology, Pharmazie, 2011, 66(2), s. 83–97.
Zhang S.N., Li X.Z., Wang Y., Zhang N., Ming Y., Shu-Min L., Lu F., Neuroprotection or neurotoxicity? new insights into the effects of Acanthopanax senticosus harms on nervous system through cerebral metabolomics analysis, Journal of Ethnopharmaco-
logy, 2014, 156, s. 290–300.
Kim H-G., Cho J-H., Yoo S-R., Lee J-S., Han J-M., Nam-Hun L., Yo-Chan A., Chang-Gue S., Antifatigue effects of Panax ginseng C.A. Meyer: A randomised, double-blind, placebo-controlled trial, PLoS ONE, 2013, 8(4), e61271.
Wesnes K.A., Ward T., McGinty A., Petrini O., The memory enhancing effects of a Ginkgo biloba/Panax ginseng combination in healthy middle-aged volunteers, Psychopharmacology (Berl), 2000, 152. s. 353–361.
Lee S.T., Chu K., Sim J.Y., Heo J.H., Kim M., Panax ginseng enhances cognitive performance in Alzheimer disease, Alzheimer Dis Assoc Disord, 2008, 22, s. 222–226.
Radad K., Gille G., Liu L.L., Rausch W.D., Use of ginseng in medicine with emphasis on neurodegenerative disorders, Journal of Pharmacological Sciences, 2006, 100, s. 175–186.
Lim J.H., Wen T.C., Matsuda S., Tanaka J., Maeda N., Peng H., Aburaya J., Ishihara K., Sakanaka M., Protection of ischaemic hippocampal neuron by ginsenosides Rb~,a main ingredient of ginseng root, Neurosciences Research, 1997, 2, s.191–200.
Teerapattarakan N., Benya-Aphikul H., Tansawat R., Wanakhachornkrai O., Tantisira M.H, Ratchane R., Neuroprotective effect of a standardized extract of Centella asiatica ECa233 in rotenone-induced parkinsonism rats, Phytomedicine, 2018, 44, s. 65–73.
Soumyanath A., Zhong Y.P., Gold S.A., Yu X., Koop D.R., Bourdette D., Gold B.G., Centella asiatica accelerates nerve regeneration upon oral administration and contains multiple active fractions increasing neurite elongation in-vitro, Journal of Pharmacy & Pharmacology, 2005, 57(9), s. 1221–1229.
Grech-Baran M., Sykłowska-Baranek K., Pietrosiuk A., Approaches of Rhodiola kirilowii and Rhodiola rosea field cultivation in Poland and their potential health benefits, Annals of Agricultural and Environmental Medicine, 2015, 22(2), s. 281–285.
Wojcik R., Siwicki A.K., Skopińska-Różewska E., Wasiutyński A., Sommer E., Furmanowa M., The effect of Chinese medicinal herb Rhodiola kirilowii extracts on cellular immunity in mice and rats, Polish Journal of Veterinary Sciences, 2009, 12(3), s. 399–405.
Shang X., He X., He X., Li M., Zhang R., Fan P., Zhang Q., Jia Z., The genus Scutellaria an ethnopharmacological and phytochemical review, Journal Ethnopharmacol, 2010, 128, s. 279–313.
Gasiorowski K., Lamer-Zarawska E., Leszek J., Parvathaneni K., Yendluri B.B., Blach-Olszewska Z, Aliev G., Flavones from the root of Scutellaria baicalensis Georgi drug of the future in neurodegeneration and neuroprotection? [in:] Laher I., editor. Systems Biology of Free Radicals and Antioxidants. Springer, Berlin, Germany 2014, s. 2305–2323.
Xiang Ng Q., Venkatanarayanan N., Xian Ho C.Y., Clinical use of Hypericum perforatum (St. John’s wort) in depression: A meta-analysis, Journal of Affective Disorders, 2017, 210, s. 211–221.
Jang F., Lim G.P., Begum A.N., Ubeda O.J., Simmons M.R., Ambegaokar S.S., Chen P.P., Kayed R., Glabe C.G., Frautschy S.A., Cole G.M., Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo, Journal of Biological Chemistry, 2005, 280, s. 5892–5901.
Sharma R.A., Gescher A.J., Steward W.P., Curcumin: The story so far, European Journal of Cancer, 2005, 41, s. 1955–1968.
Shoba G., Joy D., Joseph T., Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers, Planta Medica, 1998, 64, s. 353–356.
Downloads
The publisher's shop:
Published
How to Cite
Issue
Section
License
![Creative Commons License](http://i.creativecommons.org/l/by-nd/4.0/88x31.png)
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Stats
Number of views and downloads: 448
Number of citations: 0